OPDIVO: A TARGETED CANCER TREATMENT

Opdivo, also known as pembrolizumab, is a groundbreaking targeted medication used in the fight against cancer. This innovative drug belongs to a class of medications called immune checkpoint inhibitors. Immune checkpoint inhibitors function to the body's more info own immune system, specifically by blocking proteins that prevent T cells from attack